BridgeMD
Compares treatment options for Supraglottic Airway Devices
Official title Clinical Performance of Laryseal Clear Versus Ambu Aura 40 Laryngeal Mask Airway for Preschool Children
ClinicalTrials.gov ID: NCT07553247
What this study is testing
- What it's testing
- Preschool children have specific anatomical and physiological characteristics which necessitates careful selection of an appropriate airway management device. Supraglottic airway devices can be used in anticipated or unanticipated difficult airway providing continuous oxygenation and ventilation with less hemodynamic stress response and less postoperative complications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 6
You may be able to join if
- Consent of patient's parents or guardians of the first degree.
- American Society of Anesthesiologists (ASA) Class I or II.
- BMI: 5-85% of the children of the same age and sex.
- Patients with mallampati grade I, II
- Type of anesthesia: general anesthesia expected to last for less than 2 hours.
You likely can't join if
- Emergency surgeries.
- Expected difficult airway.
- Patients with congenital or acquired airway malformations.
- Patients with active upper respiratory tract infection at the time of surgery.
- Patients with history of gastroesophageal reflux disease (GERD).
- Patients with neuromuscular disorders affecting airway tone or respiratory function.
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Sharqia Province, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Sharqia Province, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.